Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,650 | 15,240 | 17,475 | 20,231 | 22,781 |
| Other current assets | 8 | 0 | 1 | 4 | 1 |
| TOTAL | $13,884 | $15,627 | $17,532 | $20,343 | $22,950 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 262 | 280 | 297 | 314 | 0 |
| TOTAL | $262 | $280 | $297 | $314 | $N/A |
| Total Assets | $14,146 | $15,907 | $17,829 | $20,657 | $22,950 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,612 | 788 | 1,228 | 1,298 | 1,032 |
| Accrued Expenses | 659 | 117 | 125 | 153 | 605 |
| TOTAL | $2,271 | $905 | $1,353 | $1,451 | $1,637 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,271 | $905 | $1,353 | $1,451 | $1,637 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,896 | 19,896 | 19,896 | 19,896 | 19,896 |
| Common Shares | 106,392 | 106,392 | 106,392 | 106,392 | 106,392 |
| Retained earnings | -144,031 | -140,421 | -138,612 | -133,882 | -131,256 |
| Other shareholders' equity | 1,243 | 1,243 | 1,243 | 1,243 | 1,243 |
| TOTAL | $11,875 | $15,002 | $16,476 | $19,206 | $21,313 |
| Total Liabilities And Equity | $14,146 | $15,907 | $17,829 | $20,657 | $22,950 |